5 ESSENTIAL ELEMENTS FOR PHENOBARBITAL TAPER

On initiation or discontinuation of guselkumab in patients who will be obtaining concomitant CYP450 substrates, particularly These with a narrow therapeutic index, consider monitoring for therapeutic effect.Contraindicated (1)phenobarbital will lessen the level or effect of dienogest/estradiol valerate by impacting hepatic/intestinal enzyme CYP3A4